AU2013223973B2 - Nasal delivery devices - Google Patents

Nasal delivery devices Download PDF

Info

Publication number
AU2013223973B2
AU2013223973B2 AU2013223973A AU2013223973A AU2013223973B2 AU 2013223973 B2 AU2013223973 B2 AU 2013223973B2 AU 2013223973 A AU2013223973 A AU 2013223973A AU 2013223973 A AU2013223973 A AU 2013223973A AU 2013223973 B2 AU2013223973 B2 AU 2013223973B2
Authority
AU
Australia
Prior art keywords
mouthpiece
nosepiece
delivery device
coupling member
axis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013223973A
Other languages
English (en)
Other versions
AU2013223973A1 (en
Inventor
Per Gisle Djupesland
Joseph Gordon
Michael Leclerc
Ramy A MAHMOUD
Shane SIWINSKI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optinose Inc
Original Assignee
Optinose Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48083109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2013223973(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Optinose Inc filed Critical Optinose Inc
Publication of AU2013223973A1 publication Critical patent/AU2013223973A1/en
Application granted granted Critical
Publication of AU2013223973B2 publication Critical patent/AU2013223973B2/en
Assigned to Optinose, Inc. reassignment Optinose, Inc. Request for Assignment Assignors: OPTINOSE AS
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0098—Activated by exhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0618—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0625—Mouth

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AU2013223973A 2012-02-24 2013-02-25 Nasal delivery devices Active AU2013223973B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261603093P 2012-02-24 2012-02-24
US61/603,093 2012-02-24
PCT/EP2013/053747 WO2013124492A1 (en) 2012-02-24 2013-02-25 Nasal delivery devices

Publications (2)

Publication Number Publication Date
AU2013223973A1 AU2013223973A1 (en) 2014-10-02
AU2013223973B2 true AU2013223973B2 (en) 2017-11-23

Family

ID=48083109

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013223973A Active AU2013223973B2 (en) 2012-02-24 2013-02-25 Nasal delivery devices

Country Status (17)

Country Link
US (4) US10076614B2 (enExample)
EP (1) EP2817054B2 (enExample)
JP (1) JP6286367B2 (enExample)
KR (1) KR20150003725A (enExample)
CN (1) CN104428026B (enExample)
AU (1) AU2013223973B2 (enExample)
CA (1) CA2865353C (enExample)
DK (1) DK2817054T3 (enExample)
ES (1) ES2774159T5 (enExample)
IN (1) IN2014DN07611A (enExample)
MX (1) MX358061B (enExample)
MY (1) MY170349A (enExample)
PL (1) PL2817054T3 (enExample)
RU (1) RU2644269C2 (enExample)
SG (2) SG10201600049SA (enExample)
WO (1) WO2013124492A1 (enExample)
ZA (1) ZA201406596B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
GB0311570D0 (en) 2003-05-20 2003-06-25 Optinose As Delivery device and method
GB0319119D0 (en) 2003-08-14 2003-09-17 Optinose As Delivery devices
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
GB0602980D0 (en) 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
ES2774159T5 (en) 2012-02-24 2025-09-29 Optinose Inc Nasal delivery devices
PL2817053T3 (pl) 2012-02-24 2019-01-31 Optinose As Urządzenia do podawania donosowego
JP6243360B2 (ja) 2012-02-24 2017-12-06 オプティノーズ アズ 経鼻配送装置
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
EP2868334B1 (de) 2013-11-05 2017-01-11 Benedict Gerber Nasendusche
USD743020S1 (en) * 2014-05-30 2015-11-10 Ketan C. Mehta Nasal rinse tip
ES2949052T3 (es) 2014-11-19 2023-09-25 Optinose Inc Administración intranasal
CN109939326B (zh) * 2019-04-18 2023-10-31 首都医科大学附属北京安贞医院 基于呼气压力的嗅觉训练装置
EP4073214A4 (en) 2019-12-09 2023-12-27 AAK AB (publ) Wax compositions for use in candles and methods of preparing wax compositions
PH12022551856A1 (en) 2020-01-22 2024-01-03 Seelos Therapeutics Inc Reducing side effects of nmda antagonists
AU2021297174A1 (en) 2020-06-21 2023-02-02 Massachusetts Eye And Ear Infirmary Combination verapamil and mometasone therapy for the treatment of chronic rhinosinusitis
US20240261236A1 (en) 2021-05-14 2024-08-08 Seelos Therapeutics, Inc. Methods of using nmda receptor antagonists
TW202310825A (zh) 2021-05-14 2023-03-16 美商西羅斯醫療公司 減少ｎｍｄａ受體拮抗劑之副作用
US20230285278A1 (en) * 2022-03-06 2023-09-14 Optinose, Inc. Methods for treating chronic rhinosinusitis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US794641A (en) * 1905-03-06 1905-07-11 Alfred H Ramey Inhaler.
GB2405350A (en) * 2003-08-28 2005-03-02 Optinose As A nasal delivery device operated by exhalation into a mouthpiece
WO2008122018A1 (en) * 2007-04-02 2008-10-09 Abbott Respiratory Llc Breath actuated nasal pump

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US369849A (en) * 1887-09-13 And john p
US605436A (en) 1898-06-07 Inhaler
US642748A (en) 1899-02-23 1900-02-06 Arthur Manners Inhaler.
US639808A (en) * 1899-05-04 1899-12-26 Elmer E Gardner Inhaler.
US658436A (en) * 1900-05-28 1900-09-25 Hans Hennerich Groth Insufflator.
US746749A (en) * 1903-03-18 1903-12-15 George E Seidel Nasal medicator.
US902832A (en) * 1907-09-20 1908-11-03 Edward F Philbrook Inhaler.
GB408856A (en) * 1933-08-14 1934-04-19 Wietske Van Seters Bosch Improvements in and relating to inhalers
US2546214A (en) * 1947-03-17 1951-03-27 Harold E Curry Applicator
BE483136A (enExample) * 1947-09-04 1942-06-30
US4270778A (en) * 1979-05-03 1981-06-02 Sherwood Medical Industries Inc. Tube connector with security means
DE2941132A1 (de) * 1979-10-10 1981-04-23 Loibl, Dr. med., Helmut, 8170 Bad Tölz Inhalationsansatz
US5373841A (en) * 1992-02-04 1994-12-20 Kyllonen; David M. Self-operated nasal humidifier
AU693306B2 (en) 1995-01-23 1998-06-25 Direct-Haler A/S An inhaler
US5797392C1 (en) 1996-01-22 2001-01-09 Direct Haler As Inhaler
US6012455A (en) * 1996-11-14 2000-01-11 Goldstein; Joseph Nasal air delivery apparatus
BR9809499A (pt) * 1997-05-27 2000-06-20 Direct Haler A S Inalador para medicamentos em pó
NZ514442A (en) 1999-03-03 2003-08-29 Optinose As Nasal delivery device
GB0114272D0 (en) 2001-06-12 2001-08-01 Optinose As Nasal delivery device
GB0121568D0 (en) 2001-09-06 2001-10-24 Optinose As Nasal delivery device
GB0015309D0 (en) 2000-06-21 2000-08-16 Djupesland Per G Apparatus
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB2414414B (en) † 2001-06-12 2006-03-22 Optinose As Nasal devices
GB0207422D0 (en) 2002-03-28 2002-05-08 Optinose As Nasal devices
GB0207817D0 (en) 2002-04-04 2002-05-15 Optinose As Nasal devices
GB0209494D0 (en) 2002-04-25 2002-06-05 Optinose As Nasal devices
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
GB0215904D0 (en) 2002-07-09 2002-08-21 Team Holdings Uk Ltd Drug delivery system and method
GB0300008D0 (en) 2003-01-02 2003-02-05 Optinose As Delivery devices
GB0311570D0 (en) 2003-05-20 2003-06-25 Optinose As Delivery device and method
GB0319119D0 (en) 2003-08-14 2003-09-17 Optinose As Delivery devices
ES2644717T3 (es) * 2003-10-21 2017-11-30 Direct-Haler A/S Inhalador
USD530815S1 (en) 2004-03-19 2006-10-24 Optinose As Nasal delivery device
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
US20060289006A1 (en) * 2005-06-27 2006-12-28 Kos Life Sciences, Inc. Breath actuated nasal drug delivery system
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
KR20080108085A (ko) * 2006-01-19 2008-12-11 존 시. 제퍼슨 디엠디 인코포레이션 수면무호흡증 치료기구 및 치료방법
GB0602980D0 (en) 2006-02-14 2006-03-29 Optinose As Delivery device and method
WO2007093784A1 (en) 2006-02-14 2007-08-23 Optinose As Delivery device and method
GB0604319D0 (en) 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2437488A (en) 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US7726309B2 (en) * 2006-06-05 2010-06-01 Ric Investments, Llc Flexible connector
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
WO2008042951A2 (en) * 2006-10-03 2008-04-10 Manta Product Development Inhalation devices and related methods
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB2468794B (en) † 2006-11-28 2011-07-13 Optinose As Delivery devices
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
HUE034380T2 (en) 2007-04-30 2018-02-28 Sun Pharma Advanced Res Co Ltd Inhalation device
GB0719299D0 (en) * 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
GB2471973B (en) 2007-10-03 2012-03-14 Optinose As Nasal delivery devices
WO2009066277A1 (en) * 2007-11-25 2009-05-28 Oridion Medical (1987) Ltd. Improved endoscopic bite block
WO2010029441A2 (en) 2008-09-15 2010-03-18 Optinose As Nasal delivery
AU2009319968A1 (en) 2008-11-03 2010-06-03 Merck Sharp & Dohme Corp. Elastomeric discharge member for nasal delivery device
EP2270378A1 (de) * 2009-07-02 2011-01-05 LANXESS Deutschland GmbH Flexibles Rohr
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
US9149595B2 (en) * 2011-11-21 2015-10-06 Stuart Heatherington Respiratory mask assembly
ES2774159T5 (en) 2012-02-24 2025-09-29 Optinose Inc Nasal delivery devices
JP6243360B2 (ja) 2012-02-24 2017-12-06 オプティノーズ アズ 経鼻配送装置
PL2817053T3 (pl) 2012-02-24 2019-01-31 Optinose As Urządzenia do podawania donosowego
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
US20160045687A1 (en) 2013-03-26 2016-02-18 Optinose As Nasal administration
USD725769S1 (en) 2013-05-23 2015-03-31 Optinose As Nasal delivery device
USD723156S1 (en) 2013-05-23 2015-02-24 Optinose As Nasal delivery device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US794641A (en) * 1905-03-06 1905-07-11 Alfred H Ramey Inhaler.
GB2405350A (en) * 2003-08-28 2005-03-02 Optinose As A nasal delivery device operated by exhalation into a mouthpiece
WO2008122018A1 (en) * 2007-04-02 2008-10-09 Abbott Respiratory Llc Breath actuated nasal pump

Also Published As

Publication number Publication date
IN2014DN07611A (enExample) 2015-05-15
US20150013677A1 (en) 2015-01-15
US10076614B2 (en) 2018-09-18
PL2817054T3 (pl) 2020-12-14
RU2644269C2 (ru) 2018-02-08
RU2014138495A (ru) 2016-04-10
MX358061B (es) 2018-08-03
DK2817054T3 (da) 2020-03-02
EP2817054A1 (en) 2014-12-31
HK1205699A1 (en) 2016-02-19
US20190083722A1 (en) 2019-03-21
US20250235642A1 (en) 2025-07-24
ES2774159T5 (en) 2025-09-29
CA2865353A1 (en) 2013-08-29
EP2817054B1 (en) 2019-12-04
CA2865353C (en) 2021-07-13
MY170349A (en) 2019-07-22
WO2013124492A1 (en) 2013-08-29
ES2774159T3 (es) 2020-07-17
SG10201600049SA (en) 2016-02-26
EP2817054B2 (en) 2025-07-16
JP2015507990A (ja) 2015-03-16
CN104428026B (zh) 2018-08-14
MX2014010147A (es) 2015-10-22
JP6286367B2 (ja) 2018-02-28
ZA201406596B (en) 2018-05-30
SG11201405179VA (en) 2014-10-30
CN104428026A (zh) 2015-03-18
US20220152324A1 (en) 2022-05-19
AU2013223973A1 (en) 2014-10-02
KR20150003725A (ko) 2015-01-09

Similar Documents

Publication Publication Date Title
US20250235642A1 (en) Nasal delivery devices
CA2865355C (en) Nasal delivery devices
US12502497B2 (en) Nasal delivery devices
US8146589B2 (en) Nasal devices
HK1205699B (en) Nasal delivery devices
HK1207010B (en) Nasal delivery devices
GB2402886A (en) Nasal device with varying pressure gas supply

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: OPTINOSE, INC.

Free format text: FORMER OWNER(S): OPTINOSE AS